Treatment

NEWS DESK

Mayo Clinic Q&A: Diet tips during cancer treatment

News Desk 23/04/2026

DEAR MAYO CLINIC: My husband has been diagnosed with cancer. I know his treatment will be hard on him, and I want to help in any way with his diet. What do you recommend for us?   ANSWER: Cancer treatments can take a toll on a person’s body. Your husband’s treatment may cause

NEWS DESK

Mayo Clinic maps patients’ brain waves to personalize epilepsy treatment

News Desk 03/02/2026

Mayo Clinic researchers have developed a new, personalized approach to deep brain stimulation (DBS) for people with drug-resistant epilepsy. By mapping each patient’s unique brain wave patterns, the method allows physicians to target the precise area in the brain where stimulation is most effective, moving beyond the traditional one-size-fits-all approach.   DBS

NEWS DESK

New Mayo Clinic tool exposes hidden cancer DNA changes that may drive treatment resistance

PR News Desk 21/10/2025

Some of the most harmful genetic changes in cancer are also the hardest to see. These structural alterations, deep within a tumor’s DNA, can fuel aggressive growth and evade standard testing, especially when tissue samples are small or degraded. To address this challenge, Mayo Clinic researchers have developed a new tool that illuminates these elusive […]

NEWS DESK

Prostate cancer explained: From antigen tests to treatment options

PR News Desk 15/10/2025

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That’s why Dr. Carlos Vargas, a Mayo Clinic radiation oncologist, encourages regular screening. He says the goal of screening is to detect prostate cancer early, when it’s […]

NEWS DESK

GLP-1 Stocks Surge 130% in Five Years, Beating Global Markets

PR News Desk 10/10/2025

You’ve more than likely heard of Ozempic, the diabetes drug hailed as a miracle weight-loss treatment. That drug is made by Danish healthcare giant Novo Nordisk. GLP-1 weight-loss and diabetes drugs have redefined what investors expect from healthcare in recent years. At eToro, we ran analysis on the firms producing these treatments, and they have […]

NEWS DESK

Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

PR News Desk 29/07/2025

Millions of people are affected by chronic dry mouth, or xerostomia, an agonizing side effect of damaged salivary glands. While chemotherapy and radiation treatment for head and neck cancer are the most common causes of this, aging, certain medications and other factors, including diabetes, stroke, Alzheimer’s disease and HIV/AIDS, can also cause chronic dry mouth.

NEWS DESK

The German Neuroscience Center Expands Its Operations and Introduces New Treatment Options

PR News Desk 01/07/2025

The German Neuroscience Center, one of the UAE’s leading psychology, psychiatry, and neurology clinics, has introduced two new advanced treatment protocols to enhance services for patients across its three Dubai branches. The first is Transcranial Magnetic Stimulation (TMS) therapy, a non-invasive technique primarily used to improve symptoms of severe depression, anxiety,

NEWS DESK

BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program

PR News Desk 03/04/2025

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the discontinuation of its clinical development program for ociperlimab (BGB-A1217), an anti-TIGIT antibody, as a potential treatment for lung cancer. The Independent Data Monitoring Committee recommended terminating the

NEWS DESK

‘Cannon Artes’ breaks ground supplying a massive industrial wastewater treatment

PR News Desk 05/11/2024

Cannon Artes is building a large-scale, advanced wastewater treatment and water reuse plant in one of the top three petrochemical complexes in the Middle East region. The system will cater to the water recovery needs of a gigantic polyolefin plant in Qatar, and when in operation will treat up to 25,000 cubic meters a day […]

NEWS DESK

Merck Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment

PR News Desk 12/09/2024

Merck, a leading science and technology company, today announced presentations showcasing the long-term safety profile, sustained efficacy data, and durable effect of MAVENCLAD® (cladribine tablets) in individuals with relapsing multiple sclerosis (RMS). Among 34 total MAVENCLAD presentations are data from several MAGNIFY-MS sub-studies demonstrating the impact of

NEWS DESK

A 46-year-old patient with rare autoimmune nerve disease – CIDP treated successfully at Aster Hospital Sharjah

News Desk 13/05/2024

Aster Hospital Sharjah recently helped a 46-year-old school teacher regain control of her life and career through successful treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a rare autoimmune disorder, which was leading to loss of physical strength and sensation. Mrs. Annie Cherian’s journey began six months ago when she started experiencing weakness